Vilazodone merchandised as Viibryd, is a serotonergic antidepressant. According to multiple tests carried out on its mode of action and effectiveness, Vilazodone evokes an antidepressant response just after a week of beginning treatment.
Many studies were unable to determine and prove if the drug offered more advantages compared to other antidepressants. The commonly recommended target dosage for the drug is 20 mg to 40 mg taken orally once daily with food to achieve the targeted results and dosage. If a patient mistakenly misses a dose, it should be taken immediately upon remembrance. If the patient remembers around a time where it’s already time for the next dose, it is recommended to skip the missed one and move to the next one. Two doses should not be taken at one time because that can have adverse effects.